NCT07207044

Brief Summary

FAXAge is a randomized controlled trial investigating the effects of fasting and exercise on human aging. 240 participants over the age of 65 will be divided into 4 groups - an exercise group, a fasting group, a combined exercise and fasting group and a control group. The intervention will last for one year, and tests of biomarkers of aging will be performed at baseline, after 3 months, 6 months and at the end of the intervention. A reference group of participants over the age of 20 equally distributed by age and sex will be used to train an algorithm for determination of biological age. The study will include both physical, molecular and digital biomarkers including DNA-methylation, VO2max, body composition and face- and voice-age. The main outcome of the project is DNA-methylation age at week 52. Secondary outcomes are the rest of the tested biomarkers at week 52. It is hypothesised that the intervention groups will have similar superior benefits after the 52 weeks of intervention.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
199mo left

Started Oct 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Oct 2025Aug 2042

First Submitted

Initial submission to the registry

September 23, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 3, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2027

Expected
15 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2042

Last Updated

January 28, 2026

Status Verified

September 1, 2025

Enrollment Period

1.9 years

First QC Date

September 23, 2025

Last Update Submit

January 26, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • DNA-methylation age

    Changes in predicted biological age from baseline based on DNA-methylation from isolated peripheral blood mononucleated cells after 52 weeks of intervention

    From enrollment until end of intervention at 52 weeks

Study Arms (4)

TRF

EXPERIMENTAL
Behavioral: Time-restricted feeding

EXE

EXPERIMENTAL
Behavioral: Exercise - Strength + Cardio

FAX

EXPERIMENTAL
Behavioral: Time-restricted feeding + Exercise

CON

NO INTERVENTION

Interventions

Supervised strength training 2x/week + self-administered cardio training 2x/week.

EXE

Time-restricted feeding in a 16/8 regimen - 16 hours of fast and 8 hours of eating per day.

TRF

Strength and cardio exercise 2x/week each combined with time-restricted feeding in a 16/8 regimen.

FAX

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Provision of signed and dated informed consent
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Aged \>20 years
  • In good general health meaning maximally 1 well-managed chronic disease
  • Non-smoker.

You may not qualify if:

  • Inability or unwillingness to adhere to the TRF regiment
  • Inability or unwillingness to perform the prescribed physical exercise
  • Treatment with other investigational drug or intervention within 1 year
  • \>1 hour of systematic strenuous exercise or strength training a week
  • Current time-restricted eating habits
  • Severe or dysregulated medical disease (i.e. active cancer, uncontrolled diabetes, severe pulmonary or heart disease)
  • \>1 well-managed chronic disease
  • Smoker
  • Use of systemic glucocorticoids, androgens or antiandrogens.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Copenhagen

Copenhagen, Copenhagen N, 2200, Denmark

RECRUITING

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2025

First Posted

October 3, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

August 30, 2027

Study Completion (Estimated)

August 30, 2042

Last Updated

January 28, 2026

Record last verified: 2025-09

Locations